Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients.
about
Aberrant Methylation of RASSF1A Closely Associated with HNSCC, a Meta-AnalysisHypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesisCombination of azacitidine and trichostatin A decreased the tumorigenic potential of lung cancer cells.GSTP1 methylation and polymorphism increase the risk of breast cancer and the effects of diet and lifestyle in breast cancer patients.The association of RAS association domain family Protein1A (RASSF1A) methylation states and bladder cancer risk: a systematic review and meta-analysis.Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosisAberrant promoter methylation of the CHD1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.Methylated APC and RASSF1A in multiple specimens contribute to the differential diagnosis of patients with undetermined solitary pulmonary nodules.The influence of one-carbon metabolism on gene promoter methylation in a population-based breast cancer study.Gene-Specific Promoter Methylation Status in Hormone-Receptor-Positive Breast Cancer Associates with Postmenopausal Body Size and Recreational Physical Activity.Clinical utility of RASSF1A methylation in human malignancies.Promoter Hypermethylation in White Blood Cell DNA and Breast Cancer Risk.A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis.Heterogeneous DNA Methylation Patterns in the GSTP1 Promoter Lead to Discordant Results between Assay Technologies and Impede Its Implementation as Epigenetic Biomarkers in Breast Cancer.Modification of the association between recreational physical activity and survival after breast cancer by promoter methylation in breast cancer-related genes.Sources of polycyclic aromatic hydrocarbons are associated with gene-specific promoter methylation in women with breast cancer.Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based studyDNA methylation assessment as a prognostic factor in invasive breast cancer using methylation-specific multiplex ligation dependent probe amplification.RASSF1A Promoter Methylation Levels Positively Correlate with Estrogen Receptor Expression in Breast Cancer Patients.Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification.DNA methylation modifies the association between obesity and survival after breast cancer diagnosis.DNA methylation in ductal carcinoma in situ of the breast.Quantitation of CDH1 promoter methylation in formalin-fixed paraffin-embedded tissues of breast cancer patients using differential high resolution melting analysis.Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancerROS-mediated regulation of CXCR4 in cancer.DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) studyEfficacy of the dietary histone deacetylase inhibitor butyrate alone or in combination with vitamin A against proliferation of MCF-7 human breast cancer cellsEpigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.Epigenetic profiling joins personalized cancer medicine.Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value.Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA.BRCA2 carriers with male breast cancer show elevated tumour methylation.Different methylation and microRNA expression pattern in male and female familial breast cancer.Lifetime exposure to ambient air pollution and methylation of tumor suppressor genes in breast tumors.Hypermethylation of IFN-γ in oral cancer tissues.Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.Methylation status and protein expression of RASSF1A in breast cancer patients.Gene-specific methylation profiles in BRCA-mutation positive and BRCA-mutation negative male breast cancers.Decreased methylation in the SNAI2 and ADAM23 genes associated with de-differentiation and haematogenous dissemination in breast cancers
P2860
Q28066140-014AD4B3-1276-4C87-8F0B-33D43935783CQ33556583-E528EC39-B254-4E9A-B0BF-B349CC7419F2Q33739319-6193CE33-1A38-4F2F-8DAD-B02D73CA0261Q33813245-14E78834-6327-41F6-8073-C107DEDC05E3Q34316742-A1CF9DC2-2D85-4FA0-9A7C-C3932878A271Q34471940-71BD7772-A7E4-4572-B80F-FF64023B7888Q34513567-597757A0-5F7C-4A91-ACCD-296BAC0AD8E0Q35192802-FB139791-3CFE-4D54-98DF-B8D2EA92C2D0Q35290472-739522DE-55E4-465D-B8E9-4466F7B5BEB0Q35623919-EA119209-4780-48D4-BF83-27F4D344E103Q35633512-08171E36-697B-4F66-8460-1F6B0A27A9F7Q35909621-C9EC9C74-1421-4446-AB14-4ABB5CDCE2D0Q35942162-4EAFA899-D44C-47C3-A5E1-553A5E3FEBBDQ36010918-39989725-5000-438D-9128-525316F366C1Q36096510-46EF37A6-4247-46FE-9B63-2E961E8647B8Q36286909-645AB542-5B81-457B-96BB-9E88565B1225Q36445547-8D4EA98E-8DA9-4A90-A078-720A3CF3A224Q36607318-0BC1879F-D95B-4407-BB58-6DD4DBA7C8AEQ36768855-A667AB39-94A0-41D4-A97F-D8B492081C48Q36865048-DA832663-E992-490E-BBAB-578CDFAA2C20Q36924432-FC42AEA6-6945-4280-A322-A2C8917C2846Q36961072-E0F93DC0-0027-4573-BE0F-CDEFB28BE920Q36998647-151C605D-37AA-4F7B-BE49-CEFF981F3E79Q37006733-E372F522-5CFA-4317-89A2-B04B5D036F17Q37109790-2DF14216-4B57-446D-B070-18CEE82017D4Q37287538-6A551B33-940B-4A7A-BDA6-81EED6FB71D2Q37308097-59535482-5D71-4017-9DC2-9EEFF3DD6122Q37371277-F537C7D9-3E88-41EF-83CF-F4305051DDD8Q37639092-BC76EAE0-9DEA-4E8C-AA13-7811B8F97BD5Q38115623-D3390FA9-C9A6-4BA8-8345-7B7244CC9C0CQ38388111-ACE4D811-7556-4FB2-BF0F-532539C6971CQ41049866-AE42857E-0AB0-454E-A1BE-B9EB422BD902Q41274606-4C9A6AE9-D9A9-43C0-AA58-6FD10FB17056Q44993991-558E9DBE-A5D4-49AA-AD2B-F07639F5D1C6Q47805346-E52C980D-458A-45A9-AD8A-5865EF0C5C72Q50951493-B23DF330-7A41-4EDF-94D6-69B0F14D6E69Q51341669-DE1D660F-3EB1-49BF-A41B-5DEA1D4DC79DQ54569398-3698A041-D62A-4D7E-A6C9-D909DFB1AFD2Q55030444-8939B837-B1C2-4111-809B-01E33CA4897CQ58761810-EF15B177-8866-4560-944F-99DCE6EDAC4D
P2860
Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Prognostic significance of gen ...... ion in breast cancer patients.
@ast
Prognostic significance of gen ...... ion in breast cancer patients.
@en
type
label
Prognostic significance of gen ...... ion in breast cancer patients.
@ast
Prognostic significance of gen ...... ion in breast cancer patients.
@en
prefLabel
Prognostic significance of gen ...... ion in breast cancer patients.
@ast
Prognostic significance of gen ...... ion in breast cancer patients.
@en
P2093
P2860
P1476
Prognostic significance of gen ...... ion in breast cancer patients.
@en
P2093
Alfred I Neugut
Gail Garbowski
Hanina Hibshoosh
Karina Gonzalez
Marilie D Gammon
Patrick T Bradshaw
Regina M Santella
P2860
P2888
P304
P356
10.1007/S10549-011-1712-Y
P407
P50
P577
2011-08-12T00:00:00Z